You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

Optimizing Cell Banking: A Case Study in the Partnering of Process Engineering and Industrial Modeling in Delivering Improved Efficiency and Facility Throughput

May 25, 2022 | 10:00am and 1:00pm

Jacob K. Javits Convention Center - New York, NY

Explore a real-world project which combines IPS process and industrial engineering disciplines to solve a complex challenge.

Collaboration between IPS’ process and industrial engineering experts, combining bioprocess expertise with discrete event simulation, offers an innovative option that helps quantify and predict the optimal functionality of a facility and what resources would be necessary to achieve that output. By integrating the disciplines of the process development and industrial engineering teams, IPS experts gathered the insight necessary to deliver significant improvements critical to the success of its biopharma clients. This tour will have participants explore a real-world project which combined IPS process and industrial engineering disciplines to solve a complex challenge. Stops on the tour will point out key technologies implemented to scale-up, de-risk and close off the client’s process within the footprint of the existing facility, including a discrete event simulation presentation highlighting the modeling effort and predicted facility throughput increase upon implementation of the new process.

Share this Case Study

  • Dan Swanson, PE, MBA

    Process Group Lead — IPS-Integrated Project Services, LLC

    Mr. Swanson has over 10 years of experience as a process engineer. At IPS, his role has been focused on process and facility design for cell and gene therapy projects. He has helped clients navigate the complicated issues that surround gene and cell therapy projects such as multi-product segregation, small batch size, operator safety, manual manipulations, biosafety levels, and the need for future flexibility. While his focus is on cell and gene therapy, Dan has worked on projects of all sizes across the biotech and pharmaceutical industries. His diverse background lends itself to project coordination and an emphasis on value-added design.

    Mr. Swanson has over 10 years of experience as a process engineer. At IPS, his role has been focused on process and facility design for cell and gene therapy projects. He has helped clients navigate the complicated issues that surround gene and cell therapy projects such as multi-product segregation, small batch size, operator safety, manual manipulations, biosafety levels, and the need for future flexibility. While his focus is on cell and gene therapy, Dan has worked on projects of all sizes across the biotech and pharmaceutical industries. His diverse background lends itself to project coordination and an emphasis on value-added design.

  • Kevin Swartz

    Director of Industrial Engineering - IPS-Integrated Project Services, LLC

    Mr. Swartz has over 25 years of experience in packaging machine design, engineering, equipment commissioning and integration, project management and validation/quality assurance within GMP and OEM environments. Kevin has managed and led multi-million dollar cross-functional projects to successful completion. His demonstrated skills in change management and proven leadership, with the ability to reduce cost and complexity, motivate team members, and influence and gain support from peers through executive level management, have made him a valuable asset on all projects.

    Mr. Swartz has over 25 years of experience in packaging machine design, engineering, equipment commissioning and integration, project management and validation/quality assurance within GMP and OEM environments. Kevin has managed and led multi-million dollar cross-functional projects to successful completion. His demonstrated skills in change management and proven leadership, with the ability to reduce cost and complexity, motivate team members, and influence and gain support from peers through executive level management, have made him a valuable asset on all projects.

  • George Todorov

    Senior Engineer, Process — IPS-Integrated Project Services, LLC

    Mr.Todorov has over 10 years of industry experience with early to late stage process development programs, contributing to IND-enabling studies, supporting external partnerships and consulting in the cell therapy and AAV gene therapy space. He owned strategic leadership for developing novel AAV manufacturing and analytical platforms through the evaluation of new technologies and continuous process improvement projects. George developed and implemented AAV process scale-up for transient expression systems in mammalian cells, leveraging DOE yield optimization studies. His hands-on and consulting experience includes designing and coordinating laboratory expansions and GMP facilities for various cell therapy and AAV process scale-up operations. George is a meticulous, curious, and data-driven leader focused on empowering and developing teams and organizations. He has trained and managed technical staff in AAV process development and production spanning cell thaw to final formulation.

    Mr.Todorov has over 10 years of industry experience with early to late stage process development programs, contributing to IND-enabling studies, supporting external partnerships and consulting in the cell therapy and AAV gene therapy space. He owned strategic leadership for developing novel AAV manufacturing and analytical platforms through the evaluation of new technologies and continuous process improvement projects. George developed and implemented AAV process scale-up for transient expression systems in mammalian cells, leveraging DOE yield optimization studies. His hands-on and consulting experience includes designing and coordinating laboratory expansions and GMP facilities for various cell therapy and AAV process scale-up operations. George is a meticulous, curious, and data-driven leader focused on empowering and developing teams and organizations. He has trained and managed technical staff in AAV process development and production spanning cell thaw to final formulation.

Jacob K. Javits Convention Center

10:00AM and 1:00PM

655 W 34th St | New York, NY 10001

The IPS Technologies Tours and Case Studies at Interphex will take place at the Javits Center. Please meet in the Glass Room at the Javits Center.

View our full COVID-19 statement and procedures

Read Policy

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue

We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.